ADAR1 Capital Management »

Ea Series Trust shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ea Series Trust (BOXX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ea Series Trust

Tip: Access up to 7 years of quarterly data

All positions including Ea Series Trust held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ea Series Trust by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $34M 318k 106.46

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Ea Series Trust

Empowered Funds
True Wealth Design
ADAR1 Capital Management
Insight Advisors, LLC/ PA
Wealth Enhancement Advisory Services
Cambridge Investment Research Advisors
Compass Ion Advisors
Summit Wealth & Retirement Planning
CWM
Client First Investment Management
Bank of America Corporation
Stokes Family Office
Ethos Financial Group
Castleview Partners
Integrated Wealth Concepts

View all funds holding Ea Series Trust